By
Geisel School of Medicine at Dartmouth
Published: Sept. 29, 2020, 12:58 a.m.·
Tags:
Vaccines
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted among 650 adolescents in Tanzania, a nation with high rates of TB infection, and showed that the vaccine was safe and induced immune responses against the disease.
Read More →
By
Geisel School of Medicine at Dartmouth
Published: May 11, 2017, 9:51 p.m.·
Tags:
Vaccines,
Scientific research
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
Read More →